Therefore, the investigation of IL-23 signaling pathway in models of bacterial-induced intestinal inflammation with blocked IL-10R signaling can provide insights to understanding the immune regulations in the gut of IBD patients with dysregulated IL-10 responses. The gene discussed is IL23A; the disease is irritable bowel syndrome.